JP2008530050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530050A5 JP2008530050A5 JP2007554541A JP2007554541A JP2008530050A5 JP 2008530050 A5 JP2008530050 A5 JP 2008530050A5 JP 2007554541 A JP2007554541 A JP 2007554541A JP 2007554541 A JP2007554541 A JP 2007554541A JP 2008530050 A5 JP2008530050 A5 JP 2008530050A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- butanol
- composition according
- chlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100942.1 | 2005-02-10 | ||
| EP05100942A EP1690858B1 (en) | 2005-02-10 | 2005-02-10 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| PCT/EP2006/050703 WO2006084833A1 (en) | 2005-02-10 | 2006-02-06 | Monohydrochloride salt of 1- [3- [3- (4-chlorophenyl) propoxy] propyl] -piperidine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008530050A JP2008530050A (ja) | 2008-08-07 |
| JP2008530050A5 true JP2008530050A5 (enExample) | 2009-04-02 |
| JP5072604B2 JP5072604B2 (ja) | 2012-11-14 |
Family
ID=34938687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007554541A Expired - Lifetime JP5072604B2 (ja) | 2005-02-10 | 2006-02-06 | １−［３−［３−（４−クロロフェニル）プロポキシ］プロピル］−ピペリジン一塩酸塩 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8207197B2 (enExample) |
| EP (2) | EP1690858B1 (enExample) |
| JP (1) | JP5072604B2 (enExample) |
| KR (1) | KR101344271B1 (enExample) |
| CN (1) | CN101155793B (enExample) |
| AR (1) | AR054734A1 (enExample) |
| AT (2) | ATE391716T1 (enExample) |
| CA (1) | CA2597016C (enExample) |
| CY (1) | CY1108428T1 (enExample) |
| DE (2) | DE602005005941D1 (enExample) |
| DK (1) | DK1846384T3 (enExample) |
| ES (1) | ES2309948T3 (enExample) |
| HR (1) | HRP20080446T3 (enExample) |
| ME (1) | ME01103B (enExample) |
| MX (1) | MX2007009574A (enExample) |
| PL (1) | PL1846384T3 (enExample) |
| PT (1) | PT1846384E (enExample) |
| RS (1) | RS50624B (enExample) |
| SI (1) | SI1846384T1 (enExample) |
| TW (1) | TWI393711B (enExample) |
| UY (1) | UY29369A1 (enExample) |
| WO (1) | WO2006084833A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008157094A1 (en) * | 2007-06-13 | 2008-12-24 | Cypress Bioscience, Inc. | Improving the tolerability of mirtazapine and a second active by using them in combination |
| AU2010214101A1 (en) | 2009-02-11 | 2011-09-01 | Sunovion Pharmaceuticals Inc. | Histamine H3 inverse agonists and antagonists and methods of use thereof |
| KR20120035183A (ko) | 2009-06-10 | 2012-04-13 | 선오비온 파마슈티컬스 인코포레이티드 | 히스타민 ｈ3 역 작용제 및 길항제, 및 이의 사용 방법 |
| JP2013504580A (ja) | 2009-09-11 | 2013-02-07 | スノヴィオン ファーマシューティカルズ インコーポレイテッド | ヒスタミンｈ３インバースアゴニストおよびアンタゴニストとその使用方法 |
| WO2014199935A1 (ja) * | 2013-06-10 | 2014-12-18 | 株式会社エム・エス・エス | 小胞体ストレスシグナルを抑制することによる，薬剤の副作用としての体重増加や肥満を防止するために用いられる肥満防止剤 |
| CN103435575A (zh) * | 2013-08-06 | 2013-12-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 1-（ 3-（ 3-（ 4-氯苯基）丙氧基）丙基）哌啶盐酸盐的制备方法 |
| CN104447620B (zh) * | 2014-11-28 | 2016-05-04 | 瑞阳制药有限公司 | 1-[3-[3-(4-氯苯基)丙氧基]丙基]-哌啶盐酸盐的制备方法 |
| EP3239138A1 (en) | 2016-04-25 | 2017-11-01 | Sandoz Ag | Hydrogen fumarate salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine |
| WO2020092604A1 (en) * | 2018-10-30 | 2020-05-07 | Concert Pharmaceuticals, Inc. | Deuterated pitolisant |
| IT201900013941A1 (it) | 2019-08-05 | 2021-02-05 | Procos Spa | PROCESSO PER LA SINTESI DI PITOLISANT HCl |
| CN110804026B (zh) * | 2019-11-18 | 2022-04-01 | 苏州永健生物医药有限公司 | 1- (3- (3-（4-氯苯基）丙氧基)丙基)哌啶盐酸盐的合成方法 |
| US11945788B2 (en) | 2021-06-07 | 2024-04-02 | Nuray Chemicals Private Limited | Process for preparing pitolisant hydrochloride and solid-state forms thereof |
| US11623920B2 (en) | 2021-06-07 | 2023-04-11 | Nuray Chemicals Private Limited | Process for preparing pitolisant hydrochloride and solid-state forms thereof |
| US20250059145A1 (en) * | 2021-12-29 | 2025-02-20 | Biophore India Pharmaceuticals Pvt. Ltd. | Solid forms of 1-{3-[3-(4-chlorophenyl) propoxy] propyl} piperidine hydrochloride and process for the preparation thereof |
| US20250281475A1 (en) * | 2022-05-04 | 2025-09-11 | Msn Laboratories Private Limited, R & D Center | A pharmaceutical composition of pitolisant hydrochloride and their process for the preparation |
| WO2024084379A1 (en) * | 2022-10-17 | 2024-04-25 | Biophore India Pharmaceuticals Pvt. Ltd | A NOVEL PROCESS FOR THE PREPARATION OF AMORPHOUS SOLID DISPERSION OF 1-{3-[3-(4-CHLOROPHENYL) PROPOXY] PROPYL} PIPERIDINE, HYDROCHLORIDE WITH HYDROXYPROPYL BETA-CYCLODEXTRIN (HPβCD) |
| EP4374854A1 (en) * | 2022-11-28 | 2024-05-29 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical mixture comprising amorphous pitolisant |
| JP2026511788A (ja) | 2023-03-31 | 2026-04-14 | ビオプロジェ・ファルマ | ピトリサント塩酸塩の多形形態 |
| EP4681704A1 (en) | 2024-07-18 | 2026-01-21 | BIOPROJET Pharma | New formulations of pitolisant |
| CN122374013A (zh) | 2023-10-16 | 2026-07-10 | 生物计划制药公司 | 替洛利生的新制剂和使用方法 |
| EP4732903A1 (en) | 2024-10-28 | 2026-04-29 | BIOPROJET Pharma | Co-crystals of pitolisant hydrochloride |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0982300A3 (en) * | 1998-07-29 | 2000-03-08 | Societe Civile Bioprojet | Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
-
2005
- 2005-02-10 DE DE602005005941T patent/DE602005005941D1/de not_active Expired - Lifetime
- 2005-02-10 AT AT05100942T patent/ATE391716T1/de not_active IP Right Cessation
- 2005-02-10 EP EP05100942A patent/EP1690858B1/en not_active Expired - Lifetime
-
2006
- 2006-02-06 CN CN200680008857.1A patent/CN101155793B/zh not_active Expired - Lifetime
- 2006-02-06 KR KR1020077020422A patent/KR101344271B1/ko not_active Expired - Lifetime
- 2006-02-06 ME MEP-2008-394A patent/ME01103B/me unknown
- 2006-02-06 HR HR20080446T patent/HRP20080446T3/xx unknown
- 2006-02-06 PL PL06708050T patent/PL1846384T3/pl unknown
- 2006-02-06 ES ES06708050T patent/ES2309948T3/es not_active Expired - Lifetime
- 2006-02-06 WO PCT/EP2006/050703 patent/WO2006084833A1/en not_active Ceased
- 2006-02-06 DK DK06708050T patent/DK1846384T3/da active
- 2006-02-06 CA CA2597016A patent/CA2597016C/en not_active Expired - Lifetime
- 2006-02-06 EP EP06708050A patent/EP1846384B1/en not_active Expired - Lifetime
- 2006-02-06 MX MX2007009574A patent/MX2007009574A/es active IP Right Grant
- 2006-02-06 DE DE602006001938T patent/DE602006001938D1/de not_active Expired - Lifetime
- 2006-02-06 JP JP2007554541A patent/JP5072604B2/ja not_active Expired - Lifetime
- 2006-02-06 AT AT06708050T patent/ATE402154T1/de active
- 2006-02-06 PT PT06708050T patent/PT1846384E/pt unknown
- 2006-02-06 RS RSP-2008/0482A patent/RS50624B/sr unknown
- 2006-02-06 SI SI200630073T patent/SI1846384T1/sl unknown
- 2006-02-06 US US11/815,736 patent/US8207197B2/en active Active
- 2006-02-08 AR ARP060100448A patent/AR054734A1/es not_active Application Discontinuation
- 2006-02-08 TW TW095104184A patent/TWI393711B/zh not_active IP Right Cessation
- 2006-02-09 UY UY29369A patent/UY29369A1/es not_active Application Discontinuation
-
2008
- 2008-10-21 CY CY20081101174T patent/CY1108428T1/el unknown
-
2012
- 2012-06-07 US US13/491,229 patent/US8354430B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8148372B2 (en) | Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286 | |
| CN100430394C (zh) | N-[杂芳基(哌啶-2-基)甲基]苯甲酰胺衍生物及其制备方法和它们的治疗应用 | |
| JP5452594B2 (ja) | アルキルチアゾールカルバメート誘導体、この調製、およびｆａａｈ酵素阻害剤としてのこの使用 | |
| JP2008529965A (ja) | ムスカリン性ｍ３受容体のリガンドとしてのピペリジニウムおよびピロリジニウム誘導体 | |
| JP2007504114A (ja) | ８−（１−ピペラジニル）キノリン誘導体およびｃｎｓ疾患の治療におけるそれらの使用 | |
| CN114206836B (zh) | 新型吡咯化合物 | |
| NZ251687A (en) | Oxadiazol- and thiadiazol- phenylcarbamates and -phenylureas and pharmaceutical compositions thereof | |
| US20100179118A1 (en) | Cyclic aminoalkylcarboxamide derivative | |
| HK1053109B (zh) | 取代的高哌啶基苯并咪唑化合物和含其的药物组合物以及其制法和制药用途 | |
| JPWO2000023436A1 (ja) | キナゾリノン誘導体 | |
| JP4648544B2 (ja) | （１−フェナシル−３−フェニル−３−ピペリジルエチル）ピペリジン誘導体、その製造方法およびそれを含有する医薬組成物 | |
| WO2024201139A1 (en) | Polymorph form of pitolisant hydrochloride | |
| JP2002536442A5 (enExample) | ||
| CZ300911B6 (cs) | Morfolinové deriváty, zpusob jejich prípravy a farmaceutické prostredky obsahující tyto slouceniny | |
| KR101070176B1 (ko) | Ｃｂ１에 길항 활성을 갖는 1ｈ-파이라졸-3-아마이드계 화합물 또는 1ｈ-파이라졸-3-옥소아세트아마이드계 화학물 유도체 및 이를 포함하는 약제학적 조성물 | |
| WO2009110519A1 (ja) | 新規１－アミノカルボニルピペリジン誘導体 | |
| HK40129301A (en) | Polymorph form of pitolisant hydrochloride | |
| WO2000078758A1 (en) | Novel imidazole derivatives | |
| KR20120125302A (ko) | 알킬-헤테로사이클 카르바메이트 유도체, 그의 제조법 및 그의 치료 용도 | |
| HK1155744B (en) | Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators | |
| JP2011530589A (ja) | ４−（５−｛（１ｒ）−１−［５−（３−クロロフェニル）イソオキサゾール−３−イル］エトキシ｝−４−メチル−４ｈ−１，２，４−トリアゾール−３−イル）ピリジンの新規な結晶形態 | |
| JPWO1998012195A1 (ja) | ２−カルボニルチアゾール誘導体及びその用途 |